BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19755947)

  • 21. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New wine in old bottles: the coming deluge of aggressive cutaneous cancers and precancers.
    Wassef C; Lee B; Lambert PC; Patel L; Lambert WC
    Skinmed; 2014; 12(3):183-5. PubMed ID: 25134315
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cutaneous horn, actinic keratosis and squamous cell carcinoma. Presentation of a clinical case].
    Hermida Pérez JA; Bermejo Hernández A
    Semergen; 2013 Mar; 39(2):113-6. PubMed ID: 23452540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
    Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
    Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
    Filosa A; Filosa G
    G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
    Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
    Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of actinic keratoses and early squamous cell carcinoma.
    Wheller L; Soyer HP
    Curr Probl Dermatol; 2015; 46():58-63. PubMed ID: 25561207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early detection of skin cancer].
    Treiber N; Huber MA; Scharffetter-Kochanek K; Schneider LA
    MMW Fortschr Med; 2014 Mar; 156(4):37-40. PubMed ID: 24908774
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
    Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
    Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Actinic keratoses].
    Hommel T; Szeimies RM
    Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic update on actinic keratosis.
    Sarnoff DS
    J Drugs Dermatol; 2014 Jul; 13(7):785-6. PubMed ID: 25007359
    [No Abstract]   [Full Text] [Related]  

  • 32. Squamous-cell carcinoma in situ is a fiction!
    Ackerman AB; Mones J
    J Cutan Pathol; 2009 Jan; 36(1):74-5; author reply 76. PubMed ID: 19125737
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical efficiency of dynamic observation of patients with epidermal dysplasia of the skin.
    Ziukov OL; Oshyvalova ОO
    Wiad Lek; 2018; 71(3 pt 2):635-639. PubMed ID: 29783238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From actinic keratosis to squamous cell carcinoma: evidence of morphologic and biologic progression.
    Ruini C; Witkowski AM; Cesinaro A; Teixeira De Carvalho N; Pellacani G
    J Am Acad Dermatol; 2015 Jan; 72(1 Suppl):S8-S10. PubMed ID: 25500054
    [No Abstract]   [Full Text] [Related]  

  • 36. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma.
    Fuchs A; Marmur E
    Dermatol Surg; 2007 Sep; 33(9):1099-101. PubMed ID: 17760601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of T-lymphocyte subpopulations in actinic keratosis, in situ and invasive squamous cell carcinoma of the skin.
    Stravodimou A; Tzelepi V; Papadaki H; Mouzaki A; Georgiou S; Melachrinou M; Kourea EP
    J Cutan Pathol; 2018 May; 45(5):337-347. PubMed ID: 29419888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of the histopathologic examination in the diagnosis and management of the actinic keratosis.
    Vîlcea AM; Vîlcea ID; Georgescu CV; Pătraşcu V
    Rom J Morphol Embryol; 2012; 53(4):927-34. PubMed ID: 23303015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The many clinico-pathologic faces of actinic keratosis: an atlas.
    Massone C; Cerroni L
    Curr Probl Dermatol; 2015; 46():64-9. PubMed ID: 25561208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Actinic keratoses are still actinic keratoses].
    Petit A
    Ann Dermatol Venereol; 2008 Feb; 135(2):93-6. PubMed ID: 18342088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.